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It has long been thought that signal joints, the byproducts of V(D)J recombination, are not involved in the dynamics of
the rearrangement process. Evidence has now started to accumulate that this is not the case, and that signal joints play
unsuspected roles in events that might compromise genomic integrity. Here we show both ex vivo and in vivo that the
episomal circles excised during the normal process of receptor gene rearrangement may be reintegrated into the
genome through trans-V(D)J recombination occurring between the episomal signal joint and an immunoglobulin/T-cell
receptor target. We further demonstrate that cryptic recombination sites involved in T-cell acute lymphoblastic
leukemia–associated chromosomal translocations constitute hotspots of insertion. Eventually, the identification of two
in vivo cases associating episomal reintegration and chromosomal translocation suggests that reintegration events are
linked to genomic instability. Altogether, our data suggest that V(D)J-mediated reintegration of episomal circles, an
event likely eluding classical cytogenetic screenings, might represent an additional potent source of genomic
instability and lymphoid cancer.
Citation: Vanura K, Montpellier B, Le T, Spicuglia S, Navarro JM, et al. (2007) In vivo reinsertion of excised episomes by the V(D)J recombinase: A potential threat to genomic
stability. PLoS Biol 5(3): e43. doi:10.1371/journal.pbio.0050043
Introduction
V(D)J recombination is a unique mechanism of somatic
recombination aimed to provide a large antigen receptor
repertoire in T and B cells (for review, see [1] and references
therein). During this process, the variable (V) diversity (D)
and joining (J) gene segments present within the immuno-
globulin (IG) and T-cell receptor (TCR) loci, are assembled
to form a complete VDJ exon encoding the variable region
of the IG/TCR (Figure 1A). The recombination requires the
presence of speciﬁc motifs ﬂanking all the V, D, and J gene
segments (12– and 23–recombination signal sequences
[RSSs]), and allowing the recruitment, binding, and proper
positioning of the products of the recombination activating
genes 1 and 2 (RAG-1/2). Recent data suggest that in vivo,
RAG-1/2 proteins initiate the rearrangement by performing
a ﬁrst single-strand nick at the exact border between a 12-
RSS and its adjacent coding gene segment [2]. This leads to
the capture of a 23-RSS, the formation of a 12/23 synaptic
complex in which the two DNA/protein structures are held
in close juxtaposition, and the generation of another nick at
the captured 23-RSS. Within this complex, RAG-1/2 catalyzes
a trans-esteriﬁcation reaction in which each liberated
hydroxyl group attacks the opposite DNA strand [3]; this
generates four broken ends held in a postcleavage synaptic
complex: two blunt RSSs or signal ends (SEs), and two
covalently sealed hairpin coding ends (CEs). The broken ends
are then efﬁciently repaired by the nonhomologous end-
joining (NHEJ) pathway [4–6]; on the one hand, hairpins
present at the CEs are resolved through the Artemis
endonuclease activity; when opened at bases off the apex,
hairpin opening generates overhanging ﬂaps, which, if ﬁlled
in by a DNA polymerase activity, form palindromic (P)
stretches. Nontemplated (N) nucleotides may be added de
novo by the terminal deoxynucleotidyl transferase (TdT),
and/or nucleotides may be deleted from the CEs. Ligation of
the processed CEs forms a highly diversiﬁed coding joint
(CJ). By contrast, the two SEs present in the synaptic
complex undergo only limited processing (some N addition
and rare nucleotide deletion) before joining into signal
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joints (SJs). While CJs give rise to the functional recombina-
tion products, the SJs are merely the byproduct of V(D)J
recombination.
SJs have until recently been assumed to be ‘‘harmless’’ and
irrelevant in the dynamics of the V(D)J recombination
process, but evidence now starts to accumulate that this is
not the case, and that they play unsuspected roles in events
which might compromise genomic integrity [7,8]. SJs are
indeed constituted of two functional RSSs fused back to
back, each of which therefore potentially capable of further
V(D)J rearrangement in presence of RAG-1/2. The issue of SJ
reactivity was initially addressed ex vivo by the use of
integrated minilocus and transient extrachromosomal re-
combination substrates containing germline gene segments
ﬂanked by their RSSs, and undergoing rearrangement in
culture [9–11]. Both integrative and extrachromosomal
experiments indicated that, following a ﬁrst rearrangement
by inversion, the SJ produced was indeed reactive, and could
engage into further cycles of rearrangement with RSS
partners in cis (similar to Figure 1C and 1D). In vivo and
ex vivo observations have revealed that the products
resulting from such secondary SJ rearrangements consist of
one new SJ and one hybrid RSS/coding-segment junction
(hybrid joint [HJ]), albeit with the molecular features of a CJ
(i.e., with N nucleotide insertion, and extensive nucleotide
deletion and P nucleotide addition at both the RSS and
coding segment sides; Figure 1D) [8–10,12]. This junction,
which we refer to as a ‘‘pseudo-hybrid’’ joint (WHJ), is
thereby morphologically distinguishable from CJs, SJs, and to
a large extent from ‘‘genuine’’ HJs [13–18]. WHJs constitute
therefore speciﬁc signatures of such ongoing SJ rearrange-
ment events. Interestingly, recent in vivo data suggest that
IGK/IGL rearrangement hierarchy and isotypic exclusion
might in part be achieved by ongoing SJ recombination [12].
Thus, SJ reactivity might have also evolved as part of the
dynamics of the V(D)J rearrangement process. Eventually,
the pathological counterpart of this possible physiological
extension of the V(D)J recombination capability has also
been shown to occur in cases of oncogenic chromosomal
translocation, in which ongoing rearrangement of the
resulting chromosomal SJ (CSJ) constitutes the source of
oncogene activation [8].
In the normal process of V(D)J recombination, the large
majority of SJs produced is however not retained on the
chromosome, but excised on episomal circles (ECs; Figure
1A). Because ex vivo RAG binding (or rebinding) also
efﬁciently takes place on episomal SJs (ESJs), leading to SJ
recleavage and, at least in vitro, to RAG transposition [7], we
reasoned that ongoing trans-V(D)J recombination might also
and concurrently occur (Figure 1B). This might result in the
same type of insertion of the whole circle into the genome as
previously observed in vivo for RAG-mediated transposition
[19], with the important difference that it would in this case
employ trans-V(D)J recombination [20–23], a process poten-
tially more efﬁcient than RAG transposition [15,24–28]. Both
mechanisms might obviously lead to similar genomic insta-
bility events, including oncogenic activation/deregulation. In
this report, we investigated V(D)J-mediated ESJ insertion as
an additional potent source of genomic instability and
oncogenic deregulation in lymphoid cells.
Results
ESJs Undergo trans-V(D)J Recombination Ex Vivo
To investigate the possibility that excised episomes can
reintegrate the genome through ongoing recombination of
the SJ, we ﬁrst assessed the ability of an ESJ to undergo trans-
V(D)J recombination in an ex vivo trans-recombination
substrate assay [20] (Figure 2A). Three different human ESJs
and two standard RSSs were cloned in separate extrachro-
mosomal recombination substrates; two genuine SJs were
used as ‘‘donor’’ ESJ plasmids: Jd1/Dd3 and Ki/Jj3 [12];
furthermore, an artiﬁcial Db1D ESJ was generated by muta-
genesis deletion of the 12-bp Db1 coding sequence located
between the Db1 59 and 39 RSSs; the human Jb2.7 and VjA27
gene segments were used as 12-RSS ‘‘target’’ substrates.
NIH3T3 ﬁbroblasts were cotransfected with donor and target
plasmids either with or without RAG-1/2 and TdT expression
vectors. Bulk plasmid DNA was recovered after 48 h of
culture, and junctions resulting from trans-recombination
between the ESJ and the target RSS were ampliﬁed in a single
round PCR. Primer combinations were designed to detect the
2 expected integration breakpoints complying with a 12/23
synapsis: combination (3þ 2) was used to detect putative SJs,
and combination (1 þ 4) was used to detect putative WHJs
(Figure 2A). PCR products were revealed by an IRD800-
labeled primer extension (PE) assay allowing a precise to-the-
base resolution of the ampliﬁed species (see Materials and
Methods).
In absence of the RAGs, faint and nonrecurrent PCR
products scattered at various sizes were obtained for both
primer combinations (e.g., Figure 2B, WHJ T2, ;160 bp;
additional bands are also present outside the visualized parts
of the gels). To assess the identity of such junctions, double-
nested secondary PCR were performed, and the ampliﬁcation
products were cloned and sequenced. Sequence analysis
Author Summary
Lymphoid cells recognize billions of pathogens as a result of gene
rearrangements that generate pathogen-specific B- and T-cell
receptors. This genetic reshuffling, called V(D)J recombination,
occasionally misfires and damages genomic integrity. When such
aberrations dysregulate proto-oncogenes, cancer ensues. It has
become increasingly clear that multiple oncogenes acting in
different cellular pathways can cooperate to cause cancer. Never-
theless, in the case of T-cell acute lymphoblastic leukemia, about a
third of cases display oncogene activation in the absence of
identified aberration, suggesting the presence of additional
mechanisms of chromosomal alteration. In the hunt for such
mechanisms, episomal circles (DNA segments that are excised
during V(D)J recombination) have recently drawn attention. More-
over, signal joints, short sequences formed after gene rearrange-
ments, once considered harmless, now appear to take part in events
that might compromise genomic integrity. Using ex vivo recombi-
nation assays and genetically modified mice, we demonstrate that
episomal circles may be reintegrated into the genome through
recombination occurring between the episomal signal joints and a
T-cell receptor target. Furthermore, we show that cryptic recombi-
nation sites located in the vicinity of oncogenes constitute hotspots
of episomal insertion. Altogether, our results suggest that reintegra-
tion of excised episomal circles constitute a potential source of
genomic instability and cancer in leukemia and lymphoma.
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conﬁrmed the occurrence of junctions that were not
generated by RAG-mediated recombination, but rather due
to random breaks joined through NHEJs and/or homologous
recombination pathways (not shown). Such junctions, collec-
tively referred to as ‘‘break/repair,’’ have been previously
described, and represent the RAG-independent recombina-
tion background of the trans-V(D)J assay [29].
In presence of RAGs, however, more intense and recurrent
PCR products of the expected sizes were obtained for both
PCR combinations (typical examples are illustrated for the
Db1D 3 Jb2.7 combination in Figure 2B). SJ primer
combination (3 þ 2) usually displayed one major band and
few minor species around that position, as expected from a
standard SJ, which generally presents limited nucleotide
processing. WHJ primer combination (1 þ 4), on the other
hand, displayed a pattern of intense bands around the
expected size, representing the typical spectra of largely
processed junctions. Sequence analysis of cloned products
from double-nested secondary PCR conﬁrmed the presence
of the two speciﬁc breakpoints expected from V(D)J-
mediated ongoing ESJ recombination in most cases (Figures
3 and 4; also, see below). Thus, and as anticipated from
previous studies describing ongoing recombination of SJ with
targets in cis, our results demonstrate that ESJs are also
capable of ongoing efﬁcient RAG-mediated recombination
with RSS targets in trans in the context of a 12/23 synapsis.
However, as the ESJ is formed by a functional 12-RSS and a
functional 23-RSS, both potentially able to bind the RAGs, we
next wondered if this particular structure might allow to
bypass the 12/23 rule for synapsis and give rise to additional
recombination products that we would fail to detect with the
two primer combinations used above. Double-nested PCR
with the two complementary primer combinations (1þ3) and
(2 þ 4) (Figure 2A) corresponding to a 12/12 synapsis were
thus performed on the same bulk DNA. Such combinations,
however, gave rise to only weak ampliﬁcation products.
Cloning and sequencing conﬁrmed in most cases the
occurrence of the symmetrical 12/12 SJ (1 þ 3) and WHJ (2 þ
4) (Figure S1A). This suggests that although a fraction of the
trans-recombination can occur in violation of the 12/23 rule
(as in normal V(D)J recombination), this represents a minor
population, and the large majority of the RAG-mediated
recombinants are detected with primer combinations (3þ 2)
and (1 þ 4), in accordance with a 12/23 synapsis between the
ESJ and its RSS target. Accordingly, the use of ESJ donors
made of two 12-RSS in the context of a 12-RSS target did not
give rise to any speciﬁc ampliﬁed signal, while each of the two
RSS from an ESJ donor made of two 23-RSS gave rise to
efﬁcient recombination in the context of the same 12-RSS
target (Figure S1B). In addition, the use of ESJ donor
constructs made of one functional and one nonamerless
RSS through deletional mutagenesis showed that while
deletion of the nonamer from the reactive 23-RSS completely
abolished recombination, deletion of the nonamer from the
Figure 1. Two Models of Illegitimate V(D)J Recombination
(A) V(D)J recombination generating an ESJ.
(B) Ongoing V(D)J recombination of the ESJ with a RSS target in trans, leading to reintegration of the excised EC in the genome. The specific trans-CSJ
and WHJ breakpoint signatures of the episomal reintegration are depicted.
(C) V(D)J-mediated translocation generating one trans-chromosomal CJ and one trans-CSJ.
(D) Ongoing V(D)J recombination of a CSJ in cis. The illustration depicts a CSJ generated through V(D)J-mediated translocation, but the same principle
stands for a CSJ generated through V(D)J recombination by inversion.
White triangles, 12-RSS; black triangles, 23-RSS; dotted white triangles, IG/TCR or cryptic 12-RSS; rectangles, IG/TCR gene segment or oncogene
activated through rearrangement; ellipses, RAG-1/2. Indicative chromosomes and derivative chromosomes are shown. Dented line in the WHJ and CJ
represents processing at the junction (D, nucleotide deletion; P, P nucleotide addition; N, N nucleotide addition).
doi:10.1371/journal.pbio.0050043.g001
PLoS Biology | www.plosbiology.org March 2007 | Volume 5 | Issue 3 | e430517
Reinsertion of Episomal Circles by RAG
bystander 12-RSS did not modify the overall efﬁciency
(Figure S1C). Altogether, our data clearly indicate that
trans-V(D)J recombination of ESJ obeys the 12/23 rule and is
not dependent on alternative mechanisms such as ESJ
opening by nick–nick (see below for a potential role of
nick–nick in the generation of some junctions).
trans-V(D)J Recombination Is the Major Pathway of RAG-
Mediated ESJ Recombination
We next analyzed in details the sequences issued from
recombination of the ESJ (Figure 3 and 4). SJs obtained were
morphologically undistinguishable from standard SJs, with
the presence of some N insertion and limited nucleotide
deletion (Figure 3; 3T3). Likewise, detailed analysis of the
WHJ revealed that in most sequences, end processing similar
to that of a standard CJ (nucleotide deletion, N and P
nucleotide addition) occurred at both the SE (the bystander
12-RSS of the ESJ) and the CE sides of the joint (Figure 4;
3T3). This strongly suggests that once engaged in synapsis,
and despite its ability to bind the RAGs, the bystander RSS of
the ESJ mostly behaves as a coding segment, and undergoes
therefore the hairpin formation step, followed by hairpin
resolution and further processing (Figure S2, left panel).
Nevertheless, the presence of sequences containing a full-size
ESJ bystander RSS (e.g., Jd1; Figure 4) together with the
ambiguity in the assignment of P nucleotides in presence of
TdT, suggested possible RAG binding on both ESJ RSSs, and
involvement of alternative pathways of RAG-mediated
recombination. To conﬁrm the involvement of trans-V(D)J
recombination and to test the potential contribution of
alternative pathways, the ESJ assay was repeated in the
GUETEL Artemis-deﬁcient cell line [30]. During standard
V(D)J recombination, failure to resolve hairpin CEs in
absence of the Artemis endonuclease results in the absence
Figure 2. Ex Vivo trans-V(D)J Recombination Assay
(A) Schematic representation of trans-V(D)J recombination between an ESJ (donor) and a 12-RSS (target). The expected breakpoints (one SJ and one
WHJ) are shown. The various donor/target combinations assayed are boxed. PCR primers are depicted by arrows. Nested IR800-labeled PE primers are
indicated by an asterisk.
(B) Typical example of PCR/PE assays obtained from the (Db1D) ESJ3 Jb2.7 12-RSS combination. The expected sizes of the PE products are indicated. As
the resolution of the PE assay is to the base, WHJ patterns typically show multiple bands (corresponding to the spectra of nucleotide addition and
deletion), while SJ patterns are typically centered on a major band (corresponding to no or limited nucleotide processing). PE assays shown were
performed on 0.75 ll PCR. Five independent PCRs from two independent transfections performed with (T3–T4) or without RAG-1/2 (T1–T2) are shown
for each junction.
doi:10.1371/journal.pbio.0050043.g002
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Figure 3. Breakpoint Sequences of Ex Vivo trans-V(D)J Recombinants
SJ (primer combination 3 þ 2). Top and bottom lanes depict sequences before recombination (heptamers, spacers and nonamers are specified).
Recombined clones are depicted between top and bottom lanes, with homology to the unrecombined sequences indicated by vertical lines. Lower
cases represent reactive RSS involved in the trans-V(D)J recombination reactions (specified as donor RSS and target RSS). Upper cases represent coding
segments, or bystander RSSs in the ESJ behaving like coding segments (specified as bystander RSSs). Italics indicate potential P nucleotides; bold type,
N nucleotides; heptamers and nonamers are underlined; identical sequences shown on separate lanes are issued from distinct transfections and
represent therefore independent junctions. Since identical sequences were often obtained in a given transfection, this representation might in some
cases bias the representation towards processed junctions (because they acquire distinguishing features).
doi:10.1371/journal.pbio.0050043.g003
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of CJ formation without impeding SJ formation [31–33].
Similarly, the absence of Artemis in the ESJ assay should
prevent WHJ formation without hindering the generation of
SJs. Following cotransfection of the GUETEL cell line with
the (Ki/Jj3)ESJ/VjA27 couple, PCR was performed as above
and the ampliﬁcation products cloned and sequenced. As
expected, SJs were obtained in absence of Artemis and were
undistinguishable from SJs obtained both in the Artemis-
proﬁcient 3T3 cells and in the GUETEL cell line comple-
mented with Artemis (GUETEL-A; [30] and Figure 3). Despite
the absence of Artemis, weak ampliﬁcation products were
also obtained for the WHJ PCR combination (1þ4). However,
the sequenced junctions displayed virtual absence of N
insertion and nucleotide processing (Figure 4), in sharp
contrast to the morphology of WHJs obtained in Artemis-
proﬁcient cells (3T3 and GUETEL-A). The features of the
Artemis/ junctions are however strongly reminiscent of HJs
generated by the ‘‘RAG-mediated joining’’ pathway [15–18].
RAG-mediated joining is an NHEJ-independent pathway
related to RAG transposition in which a direct attack of a
free 39 hydroxyl group from the SE into the hairpinned CE
bypasses the hairpin resolution step (illustrated in Figure S2,
right panel); this usually results in the generation of a class of
HJs displaying a full-size RSS joined to a coding sequence
with limited processing (depending on the position of the
attack in the hairpin). The presence of such junctions in the
absence of Artemis suggests that both trans-V(D)J recombi-
nation and RAG-mediated joining concurrently occur to
generate WHJs and HJs, respectively. However, the virtual
absence of such junctions in Artemis-proﬁcient cells (3T3,
Artemis-complemented) strongly suggests that RAG-medi-
ated joining constitutes a minor recombination pathway
compared to trans-V(D)J recombination. Thus, the junctions
with a full-size ESJ bystander RSS initially observed in
Artemis-proﬁcient cells are Artemis dependent, and are
either WHJs in which processing is limited due to RAG-
binding on the bystander RSS, or HJs generated through
‘‘RSS swapping’’ (Figure S2, middle panel).
Altogether, our results indicate therefore that standard
trans-V(D)J recombination is the major pathway of RAG-
mediated ESJs ongoing rearrangement.
ESJs Are as Efficient as Standard RSSs to Undergo trans-
V(D)J Recombination Ex Vivo
How efﬁcient is trans-V(D)J recombination of ESJs? In the
case of recombination between two standard coding-segment
RSSs, the frequency of trans-V(D)J recombination has been
previously shown to be reduced compared to cis-V(D)J
recombination events [20,21]. In the present case of recombi-
nation between an ESJ and its RSS target, the presence of the
second RSS in the SJ could structurally impede—or on the
contrary stimulate—RAG ﬁxation and/or activity on the
reactive one, and modify the overall recombination efﬁ-
ciency. We therefore compared in the ex vivo assay the
efﬁciency of trans-V(D)J recombination of an ESJ and a RSS
target with the efﬁciency of trans-V(D)J recombination
between two standard coding-segment RSSs (Figure 5A). To
do so, we tested two pairs of plasmids: (Jd1/Dd3) ESJ 3 Jb2.7
versus Dd33 Jb2.7, and (Db1DESJ3 Jb2.7 versus Db13 Jb2.7.
Following transfection and harvesting carried out as above,
semiquantitative primary PCR ampliﬁcation of the break-
points was performed, and serial dilutions were revealed by
PE. As illustrated in Figure 5B for the (Jd1/Dd3) ESJ 3 Jb2.7
versus Dd33 Jb2.7 couples, no signiﬁcant difference could be
seen in the formation rate of SJs in the presence of an ESJ.
Similarly, results showed comparable rates in the formation
of a WHJ relative to a CJ. We conclude that ESJs are at least as
efﬁcient as standard RSSs to undergo trans-V(D)J recombina-
tion. Altogether, this suggests that the presence of the
bystander RSS does not impede the recombination process,
whether structurally (through steric constraints) or function-
ally (through nick–nick activity). From the mechanistic point
of view, this data predicts therefore that in vivo, V(D)J-
mediated reintegration of ESJs (Figure 1B) should not be
different from V(D)J-mediated translocation (Figure 1C);
most important, both processes should use the same RSS
targets with the same efﬁciency.
Cryptic RSSs Involved in Oncogenic Translocations
Constitute Hotspots of Episomal Reintegration through
Ongoing V(D)J Recombination of an ESJ
V(D)J-mediated translocations have been shown to occur
not only between authentic RSSs from distinct IG/TCR loci,
but also between authentic RSSs and fortuitous sequences in
the genome resembling a RSS (cryptic RSSs) [34]. The
mistargeting of the RAGs towards cryptic RSSs located in
the vicinity of a silent proto-oncogene is a recurrent source
of genomic instability and oncogenesis. Erroneous targeting
of cryptic sites located near the LMO2 and TAL2 proto-
oncogenes in t(11;14)(p13;q11) and t(7;9)(q34;q32) transloca-
tions, respectively, represent prototypical examples of such
oncogenic translocations in T-cell acute lymphoblastic
leukemia (T-ALL) [8,29,35–37]. Our data above suggest that
in vivo, such cryptic sites might provide efﬁcient targets for
ESJ reintegration. To further deﬁne the potential oncogenic
properties of episomal reintegration, we next investigated in
our ex vivo assay the capacity of ESJs to target oncogenic
cryptic RSS. The human LMO2 and TAL2 cryptic RSSs and
ﬂanking sequences were cloned in a recombination substrate
plasmid (Figure 6A) and assayed in parallel to the Jb2.7
segment as a target for the (Jd1/Dd3) ESJ, using the PCR/PE
assay described above. Our results show a similar consid-
erable high rate of V(D)J-mediated recombination of the ESJ
with the LMO2 and TAL2 cryptic RSSs than with the Jb2.7
authentic RSS (Figure 6A). To further estimate the likelihood
in vivo of SJ insertion in such cryptic RSS, the LMO2 versus
the HPRT intron 1 region were assayed as competitive targets
for the (Jd1/Dd3 ESJ (Figure 6B). The HPRT intron 1 region
was chosen as a competitor because it contains a well-
described cryptic RSS classically involved in illegitimate
V(D)J-mediated deletion of exons 2–3 in vivo [38], and has
also been identiﬁed as a site of ESJ reintegration in vivo ([39];
see Discussion) as well as a region of RAG transposition in
vivo [19]. While recombination with the LMO2 cryptic RSS
constituted a hotspot of integration, no recombination could
be observed in the HPRT region, neither speciﬁcally at the
cryptic RSS, nor in the surrounding sequences (Figure 6B).
Similar results were obtained when using a target plasmid
containing a second copy of the HPRT fragment in a head-to-
tail orientation, and forming a cruciform structure (not
shown). Altogether, these data strongly suggest that cryptic
sites such as LMO2 with much higher recombinogenic
potential than the HPRT intron 1 cryptic RSS might also be
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Figure 4. Breakpoint Sequences of Ex Vivo trans-V(D)J Recombinants
WHJ and/or HJ (primer combination 1þ 4). Nucleotides in parenthesis are ambiguous and could be assigned to either side of the joint. See also legend
to Figure 3.
doi:10.1371/journal.pbio.0050043.g004
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targeted in vivo by ESJ insertion and could potentially lead to
oncogenic activation.
trans-Chromosomal WHJ Breakpoints Are Readily
Detectable In Vivo
We next investigated the physiological relevance of the
reintegration of excised episomes through ongoing SJ
recombination. As a ﬁrst approach, we sought to assess if
trans-chromosomal WHJ breakpoints were present and
detectable in vivo, and if so, to estimate their formation rate.
To do so, we designed primer combinations allowing the
ampliﬁcation of trans-TCR WHJ in mouse thymocyte DNA
(Table 1). Additional combinations designed to amplify trans-
TCR CJs and trans-TCR SJs were also performed as reference.
To detect such relatively rare trans-TCR recombination
events, we used a sensitive ﬂuctuation PCR assay allowing
the detection of less than one recombination event in a
million cells (see Materials and Methods). Positive PCR-
ampliﬁcation replicates were obtained for all trans-TCR
combinations in the broad range of ;1 in 1,000,000 cells to
1 in 10,000 cells. Sequence analysis of the PCR-ampliﬁcation
products was carried out to assess the identity of the
junctions, and revealed the presence of WHJs (Figure S3),
CJs, and SJs (not shown). Importantly, the WHJs obtained in
vivo displayed the same molecular features as observed in the
ex vivo assay, with extensive nucleotide processing on both
sides of the junctions, and N/P addition. These results clearly
demonstrate that WHJ breakpoints are indeed generated in
vivo. Furthermore, such junctions are readily detectable in
mouse thymocytes at a range similar to that of equivalent
trans-CSJs and CJs. In line with our ex vivo results, this
indicates that in vivo, SJs undergo efﬁcient ongoing cis- and/
or trans-rearrangement with RSS targets in the genome with
surprisingly high frequency. This suggests further that in
presence of RAGs, CSJs and/or ESJs are indeed very
recombinogenic structures.
Efficient In Vivo Reintegration of ECs through Ongoing
V(D)J Recombination of a SJ
Although we demonstrated above that trans-chromosomal
WHJs are readily detectable in vivo, such breakpoints do not
represent exclusive signatures of ESJ reintegration, as they
may also derive from ongoing recombination of trans-CSJs
with neighboring gene segments in cis (compare Figure 1B
and 1D). To ensure that the WHJs observed above did not
exclusively derive from CSJs issued from trans-TCR trans-
locations, and to estimate the rate of episomal reintegration
in vivo, we generated double mutant mice in which the
generation of trans-CSJs is abolished (Figure 7). Eb/ knock-
out mice, in which deletion of the 560-bp Eb core generates
an .100-fold reduction in TCRb rearrangements [40] and
TCRd/b translocations (Table 1), were crossed with a Db1GFP
knockin mouse, in which the introduction of the GFP in the
Db1 gene segment and ﬂanking 23-RSS abolishes Db1-Jb1/2
rearrangements (SS, OC, PF, unpublished data). In the
(Db1GFP 3 Eb) double-mutant (DE) mice, all TCRb chains
are consequently produced via a Vb-Db2-Jb2 rearrangement
from the Db1GFP allele (unpublished data), and all TCR
excision circles issued from Db-Jb rearrangements carry a
(Db2Jb2) ESJ (Figure 7A). Because one allele is knocked out
for Eb, and the other produces a TCRb chain, translocations
to TCRb cannot be present in TCRabþ cells from DE mice. In
absence of translocation to TCRb, no trans-TCRbd CSJ is
produced, and all Jb2.7/Jd1 WHJs are consequently issued
from episomal reintegration. As shown in Table 1, while the
rate of Jb2.7/Jd1 WHJs was decreased over ;40-fold in total
thymocytes from the Eb/mice compared to WT, the rate of
Jb2.7/Jd1 WHJs was only decreased 1.2-fold in sorted TCRabþ
cells from DE mice compared to WT.
Altogether, and in agreement with the ex vivo data, these
results clearly demonstrate that V(D)J-mediated episomal
reintegration is indeed occurring in vivo, and at a rate
comparable to that of V(D)J-mediated chromosomal trans-
location.
High Rates of Chromosomal Aberrations Combining
Insertion and Translocation
During our screen of trans-TCR SJs described above, we
noticed the presence of ampliﬁcation products larger than
expected. Out of a total of 310 PCR replicates of seven
distinct trans-TCRd/b SJ combinations, 120 were PCR positive
and four were of unexpected larger size (unpublished data).
Sequencing of the cloned products revealed that large
amplicons resulted from cis-V(D)J recombination to a cryptic
site in one case, and to a downstream gene segment in
another case; eventually, two of the four cases showed the
insertion of a sequence from the TCRd locus with features
compatible with RAG-mediated ESJ reintegration. In one of
these two cases, a ;900-bp Jd1-Dd2 fragment was inserted
into a Jb2.7/Vd2 CSJ target (Figure 8A). The breakpoints
consisted of a perfect SJ on the right arm of the insertion; on
the left arm, a junction compatible with a WHJ was found,
displaying a deletion of three nucleotides on one side of the
joint, a deletion of one nucleotide on the other side, and one
N nucleotide addition; in the second case, the same ;900-bp
Jd1-Dd2 fragment was observed inserted into a Db1/Vd2 CSJ
target (Figure 8B). Similarly, one of the breakpoints displayed
a perfect SJ, and the other breakpoint consisted of an SJ with
2 N insertions. Considering the structure of the target, this
last junction was ambiguous to assign as an SJ or a WHJ, and
could have occurred through nick–nick, V(D)J, and/or RAG-
mediated joining. Nevertheless, all junctions complied with
the 12/23 rule and with features of RAG-mediated breaks, and
it is therefore very likely that both cases represent in vivo
examples of RAG-mediated reintegration of a Jd1-Dd2 ESJ. In
the two cases, both ESJ reintegration and translocation events
occurred, and two mechanisms could therefore account for
their formation: either the trans-TCR translocations occurred
ﬁrst, and provided a trans-TCR SJ target for ESJ reintegration;
or, alternatively, ESJ reintegration in a standard RSS target
(e.g., Vd2) could have occurred ﬁrst, and provided a trans-TCR
structure and/or breakpoints prone to V(D)J-mediated trans-
location. Intriguingly, the actual frequency of this double
translocation/insertion event (2/120 ¼ ;102 trans-recombi-
nation events) was not compatible with the expected
combined frequency of each independent event: (trans-TCR
translocation ;104–106 3 reintegration ;104–106 ¼
;108–1012). Furthermore, as the assay is limited to PCR-
ampliﬁable sizes of the inserted fragment (such as the
relatively short Jd1-Dd2 episome), the apparent rate of
reintegration is probably vastly underestimated. This strongly
suggests that the two events are linked, either because CSJs
constitute preferential targets for ESJ reintegration, or
because ESJ reintegration generates genomic instability
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leading to further chromosomal abnormalities; such abnor-
malities could consist of chromosomal translocations as
detected here, or potentially more complex events which
could not be detected in the present in vivo assay.
Altogether, these data demonstrate that in vivo, SJs located
on excised ECs may be reintegrated into the genome through
trans-V(D)J recombination using standard and cryptic RSS
targets, and further suggest that this event is associated with
additional genomic instability.
Discussion
During B- and T-cell ontogeny, ECs are sequentially excised
from the genome of lymphoid cells as a result of the
hierarchically regulated D-to-J, V-to-DJ, and V-to-J rear-
rangement events. Such episomes are believed to be non-
replicative, but have nevertheless been shown to be
surprisingly stable structures, persisting until diluted out by
cell divisions [41,42]. Such episomes carry an ESJ comprised
of two functional RSSs, each of which are susceptible to (re-
)bind the RAG proteins when (re-)expressed at the various
cell maturation steps until ﬁnal downregulation [7,41,43]. On
the other hand, trans-V(D)J recombination occurring between
RSSs or cryptic RSSs located on distinct chromosomes is a
relatively common event in developing lymphocytes
[22,23,44], which has been shown to lead to recurrent
oncogenic translocations [34]. Here we show both ex vivo
and in vivo that ECs may be reintegrated into the genome
Figure 5. Semiquantitative Ex Vivo trans-V(D)J Recombination Assay
(A) Schematic representation of the comparative trans-V(D)J recombination assay. Left panel: recombination of an ESJ 23-RSS (Jd1/Dd3 or Db1D) with a
12-RSS target (Jb2.7); Right panel: recombination of a coding segment/23-RSS (Dd3 or Db1) with a 12-RSS target (Jb2.7). The expected breakpoints are
shown for each case.
(B) Typical example of semiquantitative PCR/PE assays obtained from the (Jd1/Dd3) ESJ3 Jb2.7 versus Dd33 Jb2.7 comparisons. PE assays shown were
performed on serial dilutions of PCR products.
doi:10.1371/journal.pbio.0050043.g005
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through trans-V(D)J recombination occurring between the
ESJ and an IG/TCR or one of the many cryptic RSS targets
scattered in the genome.
Molecular Mechanisms of ESJ Reintegration in Ex Vivo
Assays
We have demonstrated in ex vivo assays that the efﬁciency
of trans-V(D)J recombination of an ESJ with a RSS target is
not quantitatively different from the trans-V(D)J recombina-
tion occurring between two RSSs. This is somehow unex-
pected, because its particular structure confers additional
properties to the ESJ. ESJs are efﬁciently cleaved ex vivo and
in vitro by the nick–nick mechanism, a symmetrical nick
occurring 59 of each RSS (simultaneously or sequentially) and
generating two ﬂush SEs ending with 39 hydroxyl groups [7].
Remarkably, this process bypasses both the formation of a
hairpin intermediate and the need of synapsis with another
RSS. In the context of ongoing SJ recombination, one could
think that efﬁcient nick–nick opening of lone ESJs upon RAG
binding might prevent the occurrence of synapsis with a RSS
target, and thus considerably reduce the overall frequency of
trans-V(D)J rearrangement. Our ex vivo data clearly argue
against this assumption, and suggest that trans-V(D)J rear-
rangement is largely independent of nick–nick. This however
does not preclude that ESJ opening by nick–nick might
occasionally participate in the synapsis, and the recent in vivo
demonstration of synapsis by capture [2] provides a plausible
two-step scenario of the occurrence of nick–nick within a 12/
23 synapse (Figure S4).
Incidentally, our data provides additional evidence that HJs
can be formed ex vivo through both NHEJ-dependent and
NHEJ-independent pathways (Figure S2). RAG-mediated
joining has been initially proposed as an efﬁcient alternative
pathway of NHEJ-independent HJ formation [16–18]. How-
Figure 6. Ex Vivo SJ trans-V(D)J Recombination Assay with Cryptic RSS Targets
(A) Recombination of (Jd1/Dd3) ESJ with Jb2.7 12-RSS (white triangle with open dot), LMO2, or TAL2 cryptic 12-RSS (white triangle with filled dot). PE
assays shown were performed on 1 ll primary PCR. Five independent PCRs from two independent transfections (T1–T2, T3–T4, and T5–T6) are shown
for each junction. Similar results were obtained when LMO2 and Jb2.7 RSSs were cloned on a single plasmid as competitive targets.
(B) Competitive recombination of (Jd1/Dd3) ESJ with HPRT intron 1 cryptic RSS (black triangle with white dot) versus LMO2 cryptic RSS (white triangle
with filled dots). SJ, Jd1/HPRT; WHJ, Jd1/LMO2. PE assays shown were performed on 3 ll primary PCR using 30 cycles of PE. Five independent PCRs from
two independent transfections performed in the presence (T1–T2) or absence of RAG-1/2 (T3–T4) are shown for each junction. Similar results were
obtained when LMO2 and HPRT were cloned on separate plasmids and assayed in parallel. As described in the text, absence of specific V(D)J
recombination (e.g., in absence of RAG, T3 ;485 bp) favors the emergence of nonspecific and nonrecurrent recombination events (‘‘break-repair’’).
doi:10.1371/journal.pbio.0050043.g006
PLoS Biology | www.plosbiology.org March 2007 | Volume 5 | Issue 3 | e430524
Reinsertion of Episomal Circles by RAG
ever, conﬂicting data have been reported on the relevance of
this pathway ex vivo and in vivo [15,25–27,45,46]. In
particular, recent data indicated that at least ex vivo, RAG-
mediated joining is seldom observed in presence of full-
length RAGs, even in the absence of the concurrent NHEJ
pathway [15,46]. We ﬁnd here the presence of HJ with features
of RAG-mediated joining in the absence, but not in the
presence of Artemis, suggesting that at least ex vivo, HJ
formation is a mixed process consisting of efﬁcient RSS
‘‘swapping’’ and inefﬁcient RAG-mediated joining. Interest-
ingly, it is possible that the frequency of RAG-mediated
joining would be favored in our assay, due to the participation
of an ESJ. As mentioned above, nick–nick opening of the ESJ
in the context of a 12/23 synaptic complex would generate two
ﬂush SEs ending with 39 hydroxyl groups. While the two
reactive RSSs might be sequestered by tight binding in the SE
postcleavage complex (Figure S4), this additional free 39 OH
would provide an available substrate for hairpin attack, at
least in absence of concurrent hairpin resolution by Artemis.
Thus, nick–nick opening might participate in both trans-V(D)J
recombination and RAG-mediated joining.
In Vivo Reintegration of Excised ECs by the V(D)J
Recombinase
Using WT and DE double-mutant mice, we could estimate
that ESJ reintegration in authentic TCR RSS targets occurs in
vivo in the broad range of 1 in 1,000,000 to 1 in 10,000 mouse
thymocytes, depending on the integration site. In agreement
with our results, recent data provide further evidence for the
existence of V(D)J-mediated ESJ reintegration in vivo, and
concur with the idea that it constitutes a signiﬁcant source of
genomic instability. Using a screen for HPRT mutants,
Finette and colleagues recently identiﬁed a case in which a
Va/Ja episome was found inserted in the cryptic 23-RSS from
HPRT intron 1 [39]. This ﬁnding is all the more remarkable
given that this HPRT cryptic site has been shown to exhibit a
very low recombinogenic potential in functional assays ([47],
our unpublished data), and provides direct evidence that in
vivo, human cryptic RSSs constitute efﬁcient targets for ESJ
reintegration. In the same line, using a double selection assay
allowing for the recovery and quantiﬁcation of excision/
reinsertion events in a pre–B-cell line, Reddy et al. recently
identiﬁed three cases of V(D)J-mediated reintegration [48]. In
full agreement with our in vivo estimation, they evaluated a
rate of one reintegration out of every 100,000 V(D)J
recombinations. Considering the average number of V(D)J
recombination per B or T cell, these data suggest that the
daily lymphocyte output in human could be accompanied by
as many as 5,000 ESJ reintegration events.
A Potential Threat for Genomic Stability and Lymphoid
Neoplasia
Authentic RSSs from IG/TCR must without doubt con-
stitute preferential targets for such reintegration. However,
there are an estimated 10 million functional cryptic sites
dispersed throughout the human genome [34,47], some of
them displaying much higher recombinogenic potential than
the HPRT intron 1 cryptic RSS in which ESJ reintegration was
found [29,37]. Most important, some of them are already
known to provide recurrent targets for oncogenic (type 1)
V(D)J-mediated translocations. In T-ALL, for example, the
mistargeting of the RAGs towards such cryptic RSSs located
in the vicinity of a silent proto-oncogene is a recurrent
source of genomic instability and oncogenesis [34]. We
demonstrate in our ex vivo assay that cryptic sites involved
in oncogenic V(D)J-mediated translocations are also hotspots
for ESJ recombination; it seems thus reasonable to think that
in vivo, such cryptic RSSs might provide as efﬁcient targets
for ESJ reintegration than for chromosomal translocations.
ESJ reintegration could lead to similar oncogenic activation/
deregulation, either through the insertion of active immune
regulatory elements (e.g., the TCRd enhancer excised during
Table 1. In Vivo Rates of trans-TCR Junctions
Mouse Model Thymocyte Source trans-TCR Combination Expected Junction Fluctuation PCR Ratea Calculated Frequencyb
WT Total Vd2/Jb2.7 CJ 72/80 (90%) ;0.8 3 105
WT Total Db1/Jd2 CJ 8/31 (26%) ;1.0 3 106
WT Total Dd2/Jb2.7 CJ 25/30 (83%) ;0.6 3 105
WT Total Jb2.7/Vd2 SJ 15/60 (25%) ;1.0 3 106
WT Total Db2/Vd2 SJ/WHJc 43/60 (72%) ;0.4 3 105
WT Total Db1/Vd2 SJ/WHJc 3/20 (15%) ;0.5 3 106
WT Total Jb2.7/Dd2 SJ/WHJc 43/70 (72%) ;0.3 3 105
WT Total Jb2.7/Dd1 SJ/WHJc 15/60 (25%) ;1.0 3 106
WT Total Jb2.7/Jd2 WHJ 10/40 (25%) ;1.0 3 106
WT Total Jb2.7/Jd1 WHJ 25/40 (62%)d ;1.3 3 104
Eb/ Total Vd2/Jb2.7 CJ 0/20 (0%) , 1.0 3 107
Eb/ Total Db1/Jd2 CJ 0/34 (0%) , 1.0 3 107
Eb/ Total Dd2/Jb2.7 CJ 0/34 (0%) , 1.0 3 107
Eb/ Total Jb2.7/Jd1 WHJ 1/40 (2.5%)d ;0.3 3 105
Eb/ Total Jb2.7/Jd1 WHJ 1/40 (2.5%)d ;0.3 3 105
WT TCRabþ Jb2.7/Jd1 WHJ 14/40 (35%)d ;0.6 3 104
DE TCRabþ Jb2.7/Jd1 WHJ 12/40 (30%)d ;0.5 3 104
aFraction of positive PCR/total number of repeats (2 lg/replicate).
bCalculated from the fluctuation PCR rate using Poisson’s assumption [62].
cCombinations which could either represent trans-TCR WHJ or trans-TCR SJ.
dFor positive replicates out of the fluctuation range, PCR was repeated with 50 ng/replicate, and frequencies calculated accordingly.
doi:10.1371/journal.pbio.0050043.t001
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DRec/WJa or Va/Ja rearrangements [42,49], or the IGK
enhancer excised during KDE/Ki rearrangements [12,50]) or
through the disruption of locus silencing (e.g., the negative
regulatory element upstream of LMO2 [51,52], WA Dik; BN et
al., unpublished data).
If ESJs are at least as efﬁcient as any standard coding-
segment RSS to undergo V(D)J recombination with a RSS
target in trans, the two processes are nearly identical
mechanistically, and the RSS/cryptic RSS targets are the
same, why then has V(D)J-mediated oncogenic translocation
been largely documented in the literature, but V(D)J-
mediated reintegration never been reported up to now in
lymphoid malignancies? Higher-order spatial genome organ-
ization is a contributing factor in the formation of recurrent
translocations [53]. In contrast, increased mobility of the EC
might favor interactions and recombination of ESJs, with
targets located in parts of the genome generally segregated.
Oncogenic targets might thus be distinct for reintegration
and translocation. However, due to the multiplicity and size
range (from ,1 Kb to several Mb) of the excised episomes, as
well as the diversity of insertion targets, reintegration events
are very unlikely to be detected by routine analysis.
Particularly, and in contrast to chromosomal translocations,
episomal reintegration is invisible by standard karyotype
Figure 7. Strategy for In Vivo Detection of Episomal Reintegration in the (Db1GFP3 Eb) double-mutant (DE) mouse
(A) TCRb allelic configuration of the DE mouse. The Eb knockout prevents efficient rearrangements on allele 1, and the GFP knockin in Db1 prevents D-J
cluster 1 rearrangements on allele 2. In this configuration, all productive TCRb chains are issued from Vb rearrangements to D-J cluster 2 of allele 2.
Consequently, TCRb chain production and translocation to the TCRb locus are mutually exclusive. The generation of a TCR excision circle carrying a
(Jb2/Db2)ESJ through Db2-Jb2 rearrangements from the Db1GFP allele is depicted.
(B) Reintegration of (Jb2/Db2) ESJs in Jd1. In TCRabþ cell-sorted thymocytes from DE mice, the presence of a Jb2.7/Jd1 WHJ specifically signs the
reintegration of (Jb2/Db2)ESJ in Jd1, and is assayed by fluctuation PCR.
doi:10.1371/journal.pbio.0050043.g007
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analysis [54,55]. Few examples of identiﬁed class-switch
recombination– and RAG-mediated episomal reintegration
in lymphoid neoplasia provide proof of principle that
episomal reintegration can indeed lead to cancer, and
illustrate the complexity and unlikelihood of identifying such
events without speciﬁcally designed screens [55–57]. For
example, using complex DNA ﬁber-FISH and three-color
interphase FISH techniques on samples from follicular
lymphoma patients devoid of the hallmark t(14;18)(q32;q21)
translocation, Vaandrager et al. identiﬁed two cases in which
the BCL2 gene was excised from 18q21 and inserted into the
IGH locus at 14q32 [58]. The relatively high frequency (5%) of
such events, discovered relatively recently by Vaandrager et
al. out of an abundantly studied and characterized pathology,
illustrate well the extent to which insertional events might be
missed by routine cytogenetic and molecular analysis.
Another possibility which could account for the rarity of
cases of episomal reintegration observed in lymphoid neo-
plasia is that episomal reinsertions might generate unstable
transitory structures in the genome, leading to additional
aberration events and more complex genomic conﬁguration.
This possibility is supported by the unexpected high
frequency of two in vivo cases observed in this study,
combining ESJ reintegration and translocation events.
Similar examples of genomic instability following reintegra-
tion of episomal structures have been previously docu-
mented. In mouse plasmacytoma, Kovalchuk and colleagues
have shown that class-switch–mediated El/Sl episomal
reintegration into c-MYC favors t(12;15) translocation [56].
Although the ground of such instability is not yet clear, an
obvious possibility is that a fraction of the recombination
events might lead to incomplete insertion in vivo. Alter-
natively, the reinserted episomes might in vivo retain their
initial ‘‘open’’ chromatinized structures, and provide prefer-
Figure 8. Two In Vivo Cases of Combined Chromosomal Translocation and Reintegration of an Excised EC
The insertion of a (Jd1/Dd2) ESJ (red, upper cases) into (A) a Jb2.7/Vd2 trans-TCR or (B) a Db1/Vd2 trans-TCR CSJ target (black, lower cases) is depicted;
alternatively, ESJ reintegration could have occurred first, and provided a trans-TCR structure and/or breakpoints prone to V(D)J-mediated translocation.
Breakpoint junctions are boxed. Black bold upper case type: N nucleotides; heptamers and nonamers are underlined. PCR primers are indicated, and
shown in italics in the sequence.
doi:10.1371/journal.pbio.0050043.g008
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ential accessible targets for the recombination machinery.
The V(D)J-mediated instability of reinserted ESJs would be
especially relevant in neoplastic cells such as T-ALLs, in
which arrest of differentiation at early stages of T-cell
development leads to sustained RAG levels.
Gene proﬁling studies have shown that a substantial
fraction of the T-ALL cases display oncogenic activation in
absence of detectable chromosomal alterations [59], suggest-
ing the presence of alternative pathways of oncogenesis.
Some of them have indeed been recently discovered, and
involve episomal structures [60]. Considering the large
number of ESJs produced daily and the mechanistic
similarities between ESJ reintegration and oncogenic trans-
locations, our data suggest that reintegration of excised ECs
by the V(D)J recombinase might also account for some of
these cases, and constitute an additional potent source of
genomic instability. Deﬁnitive answer to this open question
will however await large-scale screens of human lymphoid
cancer samples with speciﬁcally adapted strategies.
Materials and Methods
Ex vivo trans-recombination substrate assay. Recombination
substrates were derived from a series previously described [29], and
the constructs are summarized in Figure S5. The various gene
segments containing the regions to recombine were ampliﬁed from
human DNA with appropriate tailed primers and cloned in the
recombination substrate using unique restriction sites (Mlu1, Sac2,
Not1). The (Ki/Jj3) ESJ was cloned (Not1/BamH1) in the pPCR-
scriptAmp vector (Stratagene, http://www.stratagene.com). Some
constructs were ﬂanked by ‘‘tag’’ sequences, which were previously
tested to be devoid of functional cryptic RSSs, and in which speciﬁc
PCR primers were designed. NIH 3T3 Swiss mouse ﬁbroblasts, and
human Artemis-deﬁcient GUETEL or Artemis-complemented GUE-
TEL-A cell lines [30] (generously supplied by J.-P. de Villartay) were
cultured in standard conditions (DMEM/10% FCS). Cells (2 3 106)
were transfected with 3 lg of each recombination substrate, 2 lg
pEBB-RAG1, 2 lg pEBB-RAG2 expression vectors (generously
supplied by C. Roman and S. Cherry), and 2 lg pCDNA3TdT
expression vector (TdT cDNA from the pTDT expression vector [a
generous gift from N. Doyen] recloned into pcDNA3 [Invitrogen,
http://www.invitrogen.com]) using Superfect (Qiagen, http://www.
qiagen.com) according to the instructions recommended by the
manufacturer. Transfected cells were transferred to 10 ml DMEM
supplemented with 10% FCS and cultured for 48 h. Cells were
subsequently trypsinized, and plasmids recovered by alkaline lysis and
phenol-chloroform extraction as previously described [29]. To test
the possibility that trans-rearrangements could occur through a ﬁrst
step of homologous recombination between the identical core
regions of the donor/acceptor plasmids, the trans-recombination
assay was also performed with ‘‘coreless’’ excised linear fragments
carrying the RSS target, and gave rise to similar results (Figure S6).
Although we cannot formally exclude the possibility that when
present, stretches of homology can facilitate the recombination
process both ex vivo and in vivo, our data suggests that recombina-
tion efﬁciently occurs through direct trans-V(D)J synapsis as
previously assumed for the assay [20].
PCR/sequencing. Breakpoints were PCR ampliﬁed from 1 ll (1/20)
harvested bulk DNA with appropriate primers (summarized in Table
S1) in the following conditions: 4 min at 948C for 25 cycles (30 s at
948C, 30 s at 648C, and 30 s at 728C), and 7 min at 728C. Secondary
double-nested PCRs were performed in the same conditions, and the
ampliﬁcation products cloned and sequenced as previously described
[29].
Semiquantitative PCR/PE assays. Breakpoints were ampliﬁed in a
single round PCR from 1 ll (1/20) harvested bulk DNA with
appropriate primers (summarized in Table S2) in the same conditions
as above, and otherwise undetectable ampliﬁcation products were
revealed by PE. PE is a sensitive alternative to Southern blot
consisting of several cycles of DNA polymerization extending from
a labeled primer until the end of a matrix DNA fragment (here a PCR
product). This generates linear (nonexponential) accumulation of
labeled fragments of speciﬁc size. PE assays were performed on 1.5 ll,
1.0 ll, and 0.75 ll of primary PCR using a nested IR800-labeled
primer in the following conditions: 5 min at 958C for 20 cycles (30 s at
958C, 15 s at 608C and 1 min at 708C), and 1 min at 708C with the
EXCEL II kit (Epicentre Biotechnologies, http://epicentre.com), using
an equal amount of all dNTPs and omitting ddNTPs. A portion (1.2
ll) of the reaction was used for running on a Li-COR 4200 DNA
sequencer (http://www.licor.com). A sequencing reaction was per-
formed in parallel on the appropriate unrecombined puriﬁed
plasmid, using the same IR800-labeled primer and in the same
reaction conditions (at the exception of the dNTP/ddNTP mix), and
was run on the same gel, providing both a precise to-the-base size
marker and a positive control for the reaction. Semiquantitative
conditions were calibrated on serial dilutions of bulk DNA and of
PCR ampliﬁcations (Figure S7A–S7C). Furthermore, to exclude
possible bias due to difference in the efﬁciency of the PCR primer
combinations used in the semiquantitative experiments, each
comparison using different sets of primers was calibrated (Figure
S7D–S7E). All PCR/PE assays were performed on at least four
independent transfections with similar results.
Flow cytometry and cell-cycle analysis. Thymocyte preparation and
cell sorting were performed as described previously [61]. Phycoery-
thrin-conjugated mAb against TCRb (H57–597), purchased from BD
PharMingen (http://www.bdbiosciences.com), was used for cell sorting
of TCRbþ thymocytes. The sorting windows were deﬁned in such a
way that only cells expressing high levels of TCRb were puriﬁed.
In vivo fluctuation PCR assay. The principle of the assay has been
previously described [29]. Detection of rare events by sensitive
double-nested PCR gives rise to ﬂuctuation in target ampliﬁcation,
depending on the presence or not of the event in the aliquot taken
from the sample. Junctions were PCR ampliﬁed from multiple
replicates of 2 lg DNA (or 50 ng for positive replicates out of the
ﬂuctuation range) isolated either from total thymocytes of WT or
Eb/ mice [40], or from TCRabþ sorted thymocytes from WT or DE
double-mutant mice, using appropriate primers (see list in Protocol
S1), and in the following conditions: 4 min at 948C for 30 cycles (30
s at 948C, 30 s at 648C, and 30 s at 728C), and 7 min at 728C.
Secondary double-nested PCRs were performed on 1 ll of each
primary PCR replicate in the same conditions, and ampliﬁcation
products were cloned and sequenced as previously described [29].
Frequencies were calculated using Poisson assumption as previously
described [62].
Supporting Information
Figure S1. Ex Vivo trans-V(D)J Recombination of ESJs Obeys the 12/23
Rule and Is Not Nick–Nick Dependent
(A) SJ and WHJ/HJ sequences obtained with the complementary
primer combinations (1þ3) and (2þ4) (see Figure 2A) corresponding
to a 12/12 synapsis.
(B) Ex vivo trans-V(D)J recombination of ESJs made of two 12-RSSs
(Db1/Dd1) or made of two 23-RSSs (Db1/Dd1) in the context of a 12-
RSS target (Jb2.7). Constructs and primers are indicated in Figure S5.
(C) Ex vivo trans-V(D)J recombination of nonamerless ESJs (indicated
as D9) in the context of a 12-RSS target. See Figure S5 for construct
and primer details.
Found at doi:10.1371/journal.pbio.0050043.sg001 (3.7 MB PDF).
Figure S2. Three Possible Pathways of a RAG-Mediated Hybrid
Junction Resulting from Ongoing Recombination of an ESJ in trans
(Left) ESJ opens by standard RAG-mediated nick and trans-ester-
iﬁcation in the context of a normal 12/23 synapsis; despite its ability
to bind the RAGs, the bystander 12-RSS of the ESJ behaves as a
coding segment, and undergoes hairpin formation. Artemis-depend-
ent hairpin resolution, further processing, and NHEJ-dependent
repair leads to a WHJ displaying processing on both sides of the joint;
nevertheless, processing may be more limited at the RSS side, due to
protection conferred by RAG binding.
(Middle) SJ opening by nick–nick in the context of a standard 12/23
synapse (see Figure S4 for details) provides an ESJ 12-RSS with a free
39 OH. As an alternative, a rare 12/12 synapsis might also provide an
ESJ 12-RSS with a free 39 OH. In an Artemis-dependent pathway,
hairpins are resolved by Artemis, processing occurs, and intermediate
products are mistakenly repaired by RSS ‘‘swapping,’’ leading to HJ
formation. Because the ESJ 12-RSS did not go through a hairpin
formation, and is bound to the RAGs, limited processing occurs at the
RSS side.
(Right) In the Artemis-independent RAG-mediated joining pathway,
a direct attack of the ESJ 12-RSS free 39 OH into the hairpinned CE
bypasses the hairpin resolution step, and results in the generation of
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a class of HJ displaying a full-size RSS joined to a coding sequence
with limited processing (depending on the position of the attack in
the hairpin). In sequences from Artemis-proﬁcient cells, the virtual
absence of joints with features of RAG-mediated joining, the minor
representation of products from 12/12 synapsis, and the presence of
nucleotide deletion/addition at both sides in most of the joints,
indicate that in the vast majority of cases, ESJs opened by standard
RAG-mediated nick and trans-esteriﬁcation in the context of a
normal 12/23 synapsis.
White triangles, 12-RSS; black triangles, 23-RSS. Dented lines
represent nucleotide processing; D, nucleotide deletion; P, P
nucleotide addition; N, N nucleotide addition. For clarity, the
generation of only one hybrid junction is represented.
Found at doi:10.1371/journal.pbio.0050043.sg002 (351 KB PDF).
Figure S3. In Vivo Detection of trans-TCRWHJs in Mouse Thymocytes
Top lanes depict germline sequences (heptamers, spacers, and
nonamers are speciﬁed; heptamers and nonamers are underlined).
Upper cases represent coding-segments. Lower cases represent
(bystander) RSSs. Recombined clones are depicted underneath with
homology to the germline sequences indicated by vertical lines. A
schematic representation of the PCR assay used for the detection of
Jb2.7/Dd(1/2) and Jb2.7/Jd2) WHJs is depicted. PCR primers used are
indicated; for the Jb2.7/Dd combinations, some cases were ambiguous
because the sequences could correspond either to WHJs with large
deletions or to processed SJs (sequences marked SJ/WHJ). Never-
theless, at least half of the cases could be unambiguously assigned to a
WHJ due to the presence of remaining nucleotides from the Dd
coding sequence. Italics indicate potential P nucleotides; bold type, N
nucleotides. Nucleotides in parenthesis are ambiguous and could be
assigned to either side of the joint.
Found at doi:10.1371/journal.pbio.0050043.sg003 (1.4 MB PDF).
Figure S4. Hypothetical Two-Step Scenario of the Occurrence of
Nick–Nick within a 12/23 Synapsis
In a ﬁrst step, both the target 12-RSSs and the ESJ 12-RSSs would
independently undergo a RAG-speciﬁc nick; in a second step, the
RAG-associated prenicked 12-RSS target would capture the 23-RSSs
of the prenicked ESJ, forming a synaptic complex and initiating the
second, symmetrical nick at the ESJ, eventually resulting to its
opening in absence of transesteriﬁcation. Although ﬂush ESJ 12-RSSs
could also be provided by rare 12/12 synapses, the two-step nick–nick
process provides a potential pathway by which HJs could be
generated in the context of a 12/23 synapse (Figure S2). Ellipses
represent RAG-1/2, regardless of stochiometry.
Found at doi:10.1371/journal.pbio.0050043.sg004 (1.2 MB PDF).
Figure S5. Schematic Representation of the Recombination Cassettes
(to Scale) Inserted in the Donor (ESJ, RSS) and Target (RSS)
Recombination Substrates
Cassettes and tags are delimited by lozenges, and PCR/PE primers are
indicated. Broken line in the (Ki/Jj3) ESJ represents core vector
sequence. M, Mlu1; N, Not1; Sc, Sac2.
Found at doi:10.1371/journal.pbio.0050043.sg005 (1.5 MB PDF).
Figure S6. Ex Vivo trans-V(D)J Recombination Assay with Coreless
Target Plasmid
The 12-RSS target is located on a linear fragment excised from the
plasmid core, and is devoid of large regions of homology with the ESJ
plasmid. See also legend to Figures 2 and 3 for PCR/PE assay and
breakpoint sequences.
Found at doi:10.1371/journal.pbio.0050043.sg006 (1.4 MB PDF).
Figure S7. Calibration of the PCR/PE Assay
The PCR/PE assay was tested by performing PCR ampliﬁcation on
serial dilutions of bulk DNA harvested from transfections.
(A) A portion (10 ll) of the reaction was loaded on ethidium
bromide–stained 1% agarose gel (M, 100-bp marker). The expected
band (319 bp) is not detectable at any dilution.
(B) A portion (1 ll) of the PCR was then used for the PE assay, in the
same conditions as described in Materials and Methods. The PCR/PE
assay for the (Jd1/Dd3) ESJ/Jb2.7 T1 transfection is shown, and
illustrates the dynamic range of the assay. Bulk DNA (1 ll) was
subsequently used as the standard condition for semiquantitative
PCR.
(C) PE assay conditions were also tested on serial dilutions of PCR
ampliﬁcation products performed on 1 ll harvested bulk DNA. Three
dilutions (1.5 ll, 1.0 ll, 0.75 ll) were used as the standard condition
for the PE assay.
(D) Primer calibrations. Triplex PCR ampliﬁcations were performed
in the same conditions as the primary PCR described in Materials and
Methods, using a 1:1:1 mix of the indicated primers, and on serial
dilutions of a 1:1 mix of plasmid DNA constructs containing the
appropriate tags (indicated in brackets); each primer couple
ampliﬁed its speciﬁc target with similar sensitivity, indicating that
there is no large bias in the PCR detection of the rearrangements due
to the use of distinct primers.
(E) Similarly, the efﬁciencies of the various labeled PE primers were
also compared on serial dilutions from primary PCR. PE assays were
performed in the same conditions as described in Materials and
Methods, using the indicated labeled primers (*), on serial dilutions
of the last dilution point (0.25 pg) of the corresponding triplex PCR.
Again, primer comparison shows a similar sensitivity, indicating that
there is no large bias in the PE detection of the rearrangements.
Found at doi:10.1371/journal.pbio.0050043.sg007 (4.4 MB PDF).
Protocol S1. List of PCR Primers
Found at doi:10.1371/journal.pbio.0050043.sd001 (29 KB DOC).
Table S1. Primer Combinations in Ex Vivo Cloning Experiments
Found at doi:10.1371/journal.pbio.0050043.st001 (17 KB XLS).
Table S2. Primer Combinations in Ex Vivo Semiquantitative Experi-
ments
Found at doi:10.1371/journal.pbio.0050043.st002 (19 KB XLS).
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